KRAMPERA, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 10.810
EU - Europa 9.088
AS - Asia 3.249
OC - Oceania 31
SA - Sud America 29
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 18
Totale 23.248
Nazione #
US - Stati Uniti d'America 10.750
GB - Regno Unito 3.272
CN - Cina 2.685
IT - Italia 1.247
SE - Svezia 924
FR - Francia 892
IE - Irlanda 867
DE - Germania 723
FI - Finlandia 633
UA - Ucraina 213
VN - Vietnam 130
BE - Belgio 92
KR - Corea 87
JP - Giappone 76
RU - Federazione Russa 71
IN - India 64
IR - Iran 59
CA - Canada 46
TR - Turchia 38
AU - Australia 29
NL - Olanda 28
ES - Italia 21
AT - Austria 20
MY - Malesia 17
EU - Europa 16
HK - Hong Kong 14
CH - Svizzera 13
RO - Romania 12
EG - Egitto 11
BR - Brasile 10
CL - Cile 9
IL - Israele 9
MX - Messico 9
PL - Polonia 8
BG - Bulgaria 7
IQ - Iraq 7
SG - Singapore 7
ID - Indonesia 5
LV - Lettonia 5
NO - Norvegia 5
PK - Pakistan 5
PT - Portogallo 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
KZ - Kazakistan 4
PH - Filippine 4
AR - Argentina 3
AZ - Azerbaigian 3
CM - Camerun 3
DK - Danimarca 3
LU - Lussemburgo 3
MV - Maldive 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CI - Costa d'Avorio 2
CO - Colombia 2
CR - Costa Rica 2
CY - Cipro 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
TH - Thailandia 2
YE - Yemen 2
ZA - Sudafrica 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 23.248
Città #
Southend 2.973
Jacksonville 1.958
Chandler 1.943
Woodbridge 1.225
Ann Arbor 885
Dublin 861
Houston 664
Ashburn 618
Beijing 384
Jinan 323
Lawrence 316
Princeton 316
Verona 309
Wilmington 307
Shenyang 295
New York 259
Nanjing 257
Hebei 140
Sindelfingen 132
Tianjin 126
Helsinki 119
Zhengzhou 106
Milan 99
Changsha 98
Nanchang 95
Haikou 90
Brussels 86
Düsseldorf 85
Ningbo 85
Redmond 80
Hangzhou 75
Seoul 72
Dong Ket 70
Taiyuan 66
Jiaxing 65
Taizhou 65
Guangzhou 63
Boardman 62
Lancaster 59
Seattle 59
Norwalk 46
Los Angeles 39
Auburn Hills 38
Fairfield 38
Kent 36
Rome 36
Lanzhou 35
Bologna 32
Dearborn 31
Fuzhou 29
Redwood City 29
San Francisco 28
Falls Church 27
Washington 20
Lappeenranta 19
Tehran 19
Chicago 16
Madrid 16
Frankfurt am Main 14
Kuala Lumpur 13
Melbourne 13
Toronto 13
Vienna 13
Zanjan 13
Xiangfen 12
Clearwater 11
Leawood 11
Paris 11
Parma 11
Amsterdam 10
Dongguan 10
Kochi 10
Palermo 10
Shenzhen 10
Cambridge 9
Edinburgh 9
Elora 9
Florence 9
Napoli 9
Nürnberg 9
Padova 9
Riva 9
Suwon 9
Tokyo 9
Torino 9
Genova 8
Perth 8
San Diego 8
Shinchiba 8
London 7
Lonigo 7
Mountain View 7
Brescia 6
Cairo 6
Châtenay-Malabry 6
Columbus 6
Lucknow 6
Montreal 6
Sacramento 6
San Mateo 6
Totale 16.809
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 418
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 258
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer 168
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 159
Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog 159
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 158
Meninges: from protective membrane to stem cell niche 152
Comparative Study of Immune Regulatory Properties of Stem Cells Derived from Different Tissues. 150
Comparison of epithelial differentiation and immune regulatory properties of mesenchymal stromal cells derived from human lung and bone marrow. 148
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 147
Quantitative fluorescence in situ hybridization on paraffin embedded tissue. 146
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 145
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 145
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 136
Domanda di brevetto per modello di utilità nr. TO2010U000026 depositata il 23 Febbraio 2010 dal titolo: "DISPOSITIVO PER LA COLTURA CELLULARE", poi convertito in brevetto modello nazionale (nr. 272134) ed internazionale (PCT/IB2011/000365). 132
IN VITRO CHARACTERIZATION OF THE DIFFERENTIATION OF MENINGEAL STEM/PRECURSOR CELLS INTO THE OLIGODENDROCYTE LINEAGE 131
Notch singalling inhibition as a multi-target therapy to overcome bone marrow microenvironment-mediated drug resistance in AML 128
Molecular characterization of msc-derived extracellular vesicles and correlation with their immunomodulatory potential 125
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 123
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 121
In vitro characterization of the differentiation of meningeal Stem/precursor cells into the oligodendrocyte lineage 119
Role of GSK-3 signalling in non-promyelocitic acute myeloid leukemia (AML) cell response to chemotherapy 118
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 117
Meninges as a niche for stem/precursor cells with neural differentiation potential during development up to adulthood. 116
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 115
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 114
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 113
Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment 111
In vitro characterization of the differentiation of meningeal stem/precursor cells into the oligodendrocyte lineage 111
Migration of meningeal cells in response to contusive spinal cord injury 111
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 110
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 110
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 109
Adipose derived mesenchimal stem cells and CNS: differentiation potential and immune suppression 108
Inhibition of GSK-3 Signalling Enhances Sensitivity of Non-Promyelocitic Acute Myeloid Leukemia (AML) Cell to Chemotherapy 106
Differential and transferable modulatory effects of mesenchymal stromal cell-derived extracellular vesicles on T, B and NK cell functions 106
Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. 105
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 104
Role of Wnt/β-Catenin Signalling in Acute Myeloid Leukemia (AML) Cell Response to Chemotherapy 103
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 102
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 102
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 102
Adipose-derived stromal cells (ASCs) 102
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 101
Immunophenotypic approach to the detection of minimal residual disease in acute leukemia 100
Meninges harbor cells expressing neural precursor markers during development and adulthood 100
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 100
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 100
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 100
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature 100
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 99
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 98
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 97
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 97
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 97
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 96
Clinical treatment of radiotherapy tissue damages by lipoaspirates transplant: a healing process mediated by adipose-derived adult stem cells (ASCs) 96
Effects of a Ceramic Biomaterial on Immune Modulatory Properties and Differentiation Potential of Human Mesenchymal Stromal Cells of Different Origin. 96
Rational of targeting WNT/beta-catenin signaling in acute myeloid leukemia (AML) 96
The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis 96
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 95
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 95
A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 94
Immunohistochemical and flow cytometric analysis of the expression of cyclin-dependent kinase 6 (CDK6, PLSTIRE) in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia 94
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 94
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice 94
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 94
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 92
Adult spinal cord meninges: A new source of neural stem cells 91
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 91
Importance of epigenetic changes in cancer etiology, pathogenesis, clinical profiling, and treatment: What can be learned from hematologic malignancies? 91
Acute Myeloid Leukemia (AML) after BMT in a patient with Acute T-Lymphoblastic Leukemia (T-ALL) in CR, with no detectable minimal residual disease by flow-cytometry 90
P21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: A potential marker of p53 tumor-suppressor gene function 90
Cytogenetic response to intensive chemotherapy in chronic myelogenous leukemia patients 90
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-a. 89
Serum level of the soluble form of CD30 molecule identifies patients with Hodgkin's disease at high risk of unfavourable outcome. 89
Sequential high dose chemotherapy with PBSC rescue in advanced hematologic malignancies 89
Immune Modulation by Mesenchymal Stem Cells 89
Early lymphoid blastic crisis following major karyotypic conversion in a chronic myeloid leukemia patient treated with interferon-alpha 89
CHARACTERIZATION OF MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLES AND CORRELATION WITH THEIR IMMUNOSUPPRESSIVE PROPERTIES TOWARDS B CELLS 89
Assetto citochinico e pattern del CD30 durante la maturazione del sistema immunitario 88
Bone marrow-, spleen- and thymus-derived mesenchymal stem cells favour the growth of myeloma cells in a mouse model 88
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 88
Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders 88
CD30 e assetto citochinico dei linfociti T, valutato mediante analisi citofluorimetrica, in un caso di sindrome da iper-IgE asintomatica 87
Preventive and therapeutic beneficial effect of adipose-derived mesenchymal stem cells in chronic EAE 87
Analysis of HFE and TFR2 gene mutations in patients with acute leukemia. 86
Extracellular Vesicles Mediate Mesenchymal Stromal Cell-Dependent Regulation of B Cell PI3K-AKT Signaling Pathway and Actin Cytoskeleton 86
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 85
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 85
Impact of allogenic and autologous bone marrow transplantation on acute non-lymphoblastic leukemia treatment: a retrospective study 84
Notch signaling in acute lymphoblastic leukemia: any role for stromal microenvironment? 84
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 84
Chapter 4: Mesenchymal stem cell isolation and expansion methodology. In: Stem Cells And Cancer Stem Cells: Therapeutic Applications in Disease and Injury 84
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 84
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 83
Stem molecular signature of adipose-derived stromal cells. 83
Serum- and stroma-free in vitro culture of primary B-CLL cells 83
Bone marrow-derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T acute lymphoblastic leukaemia: the role of interleukin 7 82
Guided differentiation of MSCs for regeneration of perimplant bone 82
Totale 10.962
Categoria #
all - tutte 70.376
article - articoli 37.285
book - libri 0
conference - conferenze 31.603
curatela - curatele 0
other - altro 233
patent - brevetti 279
selected - selezionate 0
volume - volumi 976
Totale 140.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019151 0 0 0 0 0 0 0 0 0 0 36 115
2019/20202.767 318 41 32 261 200 407 167 267 207 324 140 403
2020/20212.945 208 426 191 387 339 351 47 218 203 32 358 185
2021/20222.624 304 707 38 178 120 54 32 155 102 93 234 607
2022/20235.552 407 569 513 1.054 460 1.349 30 332 572 50 136 80
2023/20242.511 114 213 258 307 344 502 191 180 33 210 159 0
Totale 23.617